AEON Biopharma announces execution of exchange agreement with Daewoong Pharmaceutical
Source: SeekingAlpha
2025-12-15 16:24:55 ET
More on AEON Biopharma
- Seeking Alpha’s Quant Rating on AEON Biopharma
- Historical earnings data for AEON Biopharma
- Financial information for AEON Biopharma
Read the full article on Seeking Alpha
For further details see:
AEON Biopharma announces execution of exchange agreement with Daewoong Pharmaceutical
AEON Biopharma Inc. Class A
NASDAQ: AEON
AEON Trading
-2.12% G/L:
$1.05 Last:
28,033 Volume:
$1.03 Open:
AEON Latest News
March 05, 2026 04:05:00 pm
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
January 21, 2026 04:05:00 pm
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
December 15, 2025 04:05:00 pm
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong
November 20, 2025 08:30:00 am
AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling
AEON Stock Data
$26,568,211
20,040,022
N/A
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Irvine
